Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ngm Biopharmaceuticals Inc (NGM)

Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ngm Biopharmaceuticals Inc 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 USA

www.ngmbio.com P: 650-243-5555

Description:

NGM Biopharmaceuticals Inc. is focused on developing novel therapeutics for underlying cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's product pipeline consists of NGM282, NGM313, NGM120, NGM217, NGM621, NGM386 and NGM395 which are in clinical stage. NGM Biopharmaceuticals Inc. is based in San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 128,531
Enterprise Value, $K 69,711
Shares Outstanding, K 83,462
Annual Sales, $ 4,420 K
Annual Net Income, $ -142,380 K
Last Quarter Sales, $ 160 K
Last Quarter Net Income, $ -27,670 K
EBIT, $ -151,460 K
EBITDA, $ -154,790 K
60-Month Beta 1.27
% of Insider Shareholders 35.90%
% of Institutional Shareholders 75.74%
Float, K 53,499
% Float 64.10%
Short Volume Ratio 0.73

Growth:

1-Year Return -61.11%
3-Year Return -93.94%
5-Year Return -90.41%
5-Year Revenue Growth -95.93%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 03/11/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -1.72
EPS Growth vs. Prev Qtr 5.71%
EPS Growth vs. Prev Year 26.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NGM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -77.85%
Return-on-Assets % -67.77%
Profit Margin % -3,221.27%
Debt/Equity 0.00
Price/Sales 29.48
Price/Cash Flow N/A
Price/Book 0.86
Book Value/Share 1.80
Interest Coverage -2.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar